急性感染诱发急性心肌梗死的临床特点及炎症指标相关分析

余雯静; 王大新

doi:10.13201/j.issn.1001-1439.2021.07.006

急性感染诱发急性心肌梗死的临床特点及炎症指标相关分析

余雯静¹,
王大新^2, ,

- 1. 大连医科大学(辽宁大连, 116044);
- 2. 江苏省苏北人民医院心血管内科
基金项目:
国家重大项目973计划(No:2007CB936104)

江苏省“六大人才高峰”(No:2014-SWYY-052)

详细信息

通讯作者: 王大新,E-mail:daxinw@126.com

中图分类号: R542.2

收稿日期: 2021-01-19

The correlation analysis of clinical characteristics and inflammation indexes of acute myocardial infarction induced by acute infection

YU Wenjing¹,
WANG Daxin^2, ,

- 1. Dalian Medical University, Dalian, Liaoning, 116044, China;
- 2. Subei People's Hospital in Jiangsu Province

More Information

Corresponding author: WANG Daxin, E-mail: daxinw@126.com

Received Date: 19 January 2021

摘要

摘要: 目的:分析急性感染诱发急性心肌梗死(AMI)的临床特点及血清学指标中炎症相关指标的差异。方法:选择2019年1月—2020年6月于江苏省苏北人民医院有明确感染症状或检查证据的AMI患者79例,设为感染AMI组;将明确无感染证据的AMI患者80例,设为非感染AMI组;将有明确感染证据而未发生AMI的患者80例,设为感染无AMI组;将本院其他原因住院的排除冠心病、感染等相关疾病的患者80例,设为对照组。对4组临床资料及中性粒细胞与淋巴细胞比值(NLR)、平均血小板体积(MPV)、血清胱抑素C(Cys-C)、血浆D-二聚体/纤维蛋白原比值(D/F比值)进行研究。结果:感染AMI组与非感染AMI组之间在年龄、性别、发病到入院时间、住院时间、是否为STEMI、主要不良事件、入院时心率、左室射血分数、空腹血糖、入院脑钠肽、C反应蛋白之间差异有统计学意义(P<0.05),感染AMI组与感染无AMI组之间在年龄、性别、糖尿病、高血压病、高脂血症、慢性肾脏病之间差异存在统计学意义(P<0.05)。感染AMI组患者的NLR、Cys-C、D/F比值比非感染AMI组患者更高(P<0.05)。感染AMI组中,MPV、Cys-C比感染无AMI组更高(P<0.05),而NLR、D/F比值之间差异无统计学意义。结论:感染AMI组在主要心脏不良事件发生率、住院天数及炎症相关指标上更高,急性感染诱发AMI与感染无AMI患者的MPV、Cys-C存在差异。
- 感染 /
- 急性心肌梗死 /
- 中性粒细胞与淋巴细胞比值 /
- 血清胱抑素C /
- D-二聚体/纤维蛋白原比值
Abstract: Objective: To investigate the clinical characteristics of acute myocardial infarction induced by acute infection.Methods: The 79 patients with acute myocardial infarction were selected as the infection group. The 80 patients with acute myocardial infarction without evidence of infection were selected to the non-infected group. The 80 patients with clear evidence of infection but no AMI were set as the infected non-AMI group. The 80 patients without coronary heart disease, infection and other related diseases were set as the control group. The four groups were detected neutrophil to lymphocyte ratio(NLR), mean platelet volume(MPV), serum cystatin C(Cys-C) plasma D-dimer/fibrinogen ratio(D/F ratio).Results: There were differences in age, gender, time from onset to admission, length of stay, whether it was STEMI, major adverse events, heart rate at admission, LVEF, fasting blood glucose, admission BNP, and CRP between the infected AMI group and the non-infected AMI group(P<0.05). There were significant differences in age, gender, diabetes, hypertension, hyperlipidemia, and chronic kidney disease between the infected AMI group and the infected non-AMI group(P<0.05). The NLR, Cys-C and D/F ratios of patients in the infected AMI group were higher than those in the non-infected AMI group(P<0.05). In the infected AMI group, MPV and Cys-C were higher than those in the non-AMI group(P<0.05).Conclusion: Acute myocardial infarction induced by acute infection has higher MACE incidence, hospitalization days, and inflammation-related indicators than non-infected AMI.
- infection /
- acite myocardial infarction /
- neutrophil to lymphocyte ratio /
- mean platelet tvolume /
- cystatin C

HTML全文

参考文献(32)

[1]	Musher DM,Abers MS,Corrales-Medina VF.Acute infection and myocardial infarction[J].N Engl J Med,2019,380(2):171-176.
[2]	Corrales-Medina VF,Suh KN,Rose G,et al.Cardiac complications in patients with community-acquired pneumonia:a systematic review and meta-analysis of observational studies[J].PLoS Med,2011,8(6):e1001048.
[3]	Singh M,Khan K,Fisch E,et al.Acute cardiac events in patients with severe limb infection[J].Int J Low Extrem Wounds,2018,17(4):261-267.
[4]	Ashraf S,Ilyas S,Alraies MC.Acute coronary syndrome in the time of the COVID-19 pandemic[J].Eur Heart J,2020,41(22):2089-2091.
[5]	Choudry FA,Hamshere SM,Rathod KS,et al.High thrombus burden in patients with COVID-19 presenting with ST-segment elevation myocardial infarction[J].J Am Coll Cardiol,2020,76(10):1168-1176.
[6]	Cho KH,Jeong MH,Ahmed K,et al.Value of early risk stratification using hemoglobin level and neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention[J].Am J Cardiol,2011,107(6):849-856.
[7]	Bhat T,Teli S,Rijal J,et al.Neutrophil to lymphocyte ratio and cardiovascular diseases:a review[J].Expert Rev Cardiovasc Ther,2013,11(1):55-59.
[8]	Endler G,Klimesch A,Sunder-Plassmann H,et al.Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease[J].Br J Haematol,2002,117(2):399-404.
[9]	Elsenberg EH,van Werkum JW,van de Wal RM,et al.The influence of clinical characteristics,laboratory and inflammatory markers on 'high on-treatment platelet reactivity' as measured with different platelet function tests[J].Thromb Haemost,2009,102(4):719-727.
[10]	邱崇荣,眭建,张倩,等.老年急性心肌梗死患者应激血糖和血清胱抑素C及肾小球滤过率与近期预后的关系[J].中华老年医学杂志,2016,35(2):163-167.
[11]	Bengtsson E,To F,Grubb A,et al.Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice[J].Atherosclerosis,2005,180(1):45-53.
[12]	Yang S,Song L,Zhao L,et al.Predictive value of cystatin C in people with suspected or established coronary artery disease:A meta-analysis[J].Atherosclerosis,2017,263:60-67.
[13]	Alvarez-Perez FJ,Castelo-Branco M,Alvarez-Sabin J.Usefulness of measurement of fibrinogen,D-dimer,D-dimer/fibrinogen ratio,C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke[J].J Neurol Neurosurg Psychiatry,2011,82(9):986-992.
[14]	饶甲环,马煜盛,龙洁旎,等.血浆D-二聚体/纤维蛋白原比值及超敏C反应蛋白在急性冠脉综合征中的临床价值[J].解放军医学杂志,2018,43(11):943-949.
[15]	Rose JJ,Voora D,Cyr DD,et al.Gene expression profiles link respiratory viral infection,platelet response to aspirin,and acute myocardial infarction[J].PLoS One,2015,10(7):e0132259.
[16]	Chen L,Li X,Chen M,et al.The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2[J].Cardiovasc Res,2020,116(6):1097-1100.
[17]	袁梅,刘佳,史河水.新型冠状病毒肺炎心肌损伤临床病理与影像学研究进展[J].临床心血管病杂志,2021,37(02):105-109.
[18]	Crea F,Libby P.Acute coronary syndromes:the way forward from mechanisms to precision treatment[J].Circulation,2017,136(12):1155-1166.
[19]	Drosatos K,Lymperopoulos A,Kennel PJ,et al.Pathophysiology of sepsis-related cardiac dysfunction:driven by inflammation,energy mismanagement,or both?[J].Curr Heart Fail Rep,2015,12(2):130-140.
[20]	Logeart D,Beyne P,Cusson C,et al.Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain[J].Am Heart J,2001,141(2):247-253.
[21]	周小敏,赵展庆,林奇栋,等.心肌梗死患者血清TNF-α、IL-1β、IL-18水平与急性呼吸衰竭病情的关系[J].临床急诊杂志,2019,20(6):475-479,483.
[22]	Putot A,Jeanmichel M,Chague F,et al.Type 2 myocardial infarction:a geriatric population-based model of pathogenesis[J].Aging Dis,2020,11(1):108-117.
[23]	王飞,李娴.危重症患者并发2型急性心肌梗死诊治研究进展[J].临床急诊杂志,2019,20(11):910-912.
[24]	Sandoval Y,Smith SW,Sexter A,et al.Type 1 and 2 myocardial infarction and myocardial injury:clinical transition to high-sensitivity cardiac troponin I[J].Am J Med,2017,130(12):1431-1439.e4.
[25]	Adamsson Eryd S,Smith JG,Melander O,et al.Incidence of coronary events and case fatality rate in relation to blood lymphocyte and neutrophil counts[J].Arterioscler Thromb Vasc Biol,2012,32(2):533-539.
[26]	Balta S,Demirkol S,Ay SA,et al.Serum cystatin-C levels correlate with endothelial dysfunction in patients with the metabolic syndrome[J].J Intern Med,2013,274(2):200-201.
[27]	Li W,Sultana N,Siraj N,et al.Autophagy dysfunction and regulatory cystatin C in macrophage death of atherosclerosis[J].J Cell Mol Med,2016,20(9):1664-1672.
[28]	Wuillemin WA,Korte W,Waser G,et al.Usefulness of the D-dimer/fibrinogen ratio to predict deep venous thrombosis[J].J Thromb Haemost,2005,3(2):385-387.
[29]	Levine GN,Bates ER,Blankenship JC,et al.2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction:An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J].Circulation,2016,133(11):1135-1147.
[30]	何婷婷,庞丽霞,王桂云.前负荷剂量替格瑞洛对PCI后冠状动脉血流、炎症反应及心肌酶谱的影响[J].临床心血管病杂志,2019,35(4):330-334.
[31]	Lancellotti P,Musumeci L,Jacques N,et al.Antibacterial activity of ticagrelor in conventional antiplatelet dosages against antibiotic-resistant gram-positive bacteria[J].JAMA Cardiol,2019,4(6):596-599.
[32]	Rigatelli G,Zuin M,Rigatelli A,et al.Protective activity of Ticagrelor against bacterial infection in acute myocardial infarction patients[J].Eur J Intern Med,2019,70:e19-e21.